{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:45:44Z","timestamp":1793270744156,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["IFD: 8088-00023B"],"award-info":[{"award-number":["IFD: 8088-00023B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Many patients suffering from schizophrenia spectrum disorders continue having distressing auditory hallucinations in spite of treatment with antipsychotic medication. The aim of this trial is to examine the effect of a targeted virtual reality therapy for persistent auditory hallucinations in individuals with psychosis. The trial explores whether this type of therapy can decrease the severity, frequency and distress of auditory hallucinations and, additionally, whether it can reduce clinical symptoms and enhance daily functioning in individuals with psychosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study is a randomised, assessor-blinded parallel-group superiority clinical trial, allocating a total of 266 patients to either the experimental intervention or supportive counselling. The participants will be randomised to either (1) seven sessions of virtual reality therapy or (2) seven sessions of supportive counselling to be delivered within the first 12 weeks after inclusion in the study. All participants will be assessed at baseline and 12 and 24 weeks post-baseline. Independent assessors blinded to the treatment allocation will evaluate the outcome. The primary outcome is the level of auditory hallucinations measured with the Psychotic Symptoms Rating Scales (PSYRATS-AH) total score at the cessation of treatment at 12 weeks. Secondary outcomes are frequency of auditory hallucinations, the distress caused by auditory hallucinations, perceived voice power, patient acceptance of voices, patients\u2019 ability to respond to voices in an assertive way and social and daily function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Promising evidence of the efficacy of this immersive virtual reality-based therapy for auditory hallucinations exist, but evidence needs to be established in a large, methodological rigorous trial. If the therapy proves to be beneficial in reducing the severity of refractory auditory hallucinations, a large group of patients with schizophrenia and related disorders could be the target group of this short-term psychotherapeutic intervention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06683-1","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T07:07:13Z","timestamp":1663052833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-7750","authenticated-orcid":false,"given":"L. C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mariegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Vernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hjorth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. B.","family":"Glenth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"issue":"5","key":"6683_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamapsychiatry.2014.16","volume":"71","author":"CB Pedersen","year":"2014","unstructured":"Pedersen CB, Mors O, Bertelsen A, et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry. 2014;71(5):573\u201381. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.16.","journal-title":"JAMA Psychiatry."},{"issue":"4","key":"6683_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","volume":"15","author":"W R\u00f6ssler","year":"2005","unstructured":"R\u00f6ssler W, Joachim Salize H, Van Os J, Riecher-R\u00f6ssler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15(4):399\u2013409. https:\/\/doi.org\/10.1016\/j.euroneuro.2005.04.009.","journal-title":"Eur Neuropsychopharmacol."},{"issue":"1-2","key":"6683_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.schres.2015.07.021","volume":"168","author":"SF Austin","year":"2015","unstructured":"Austin SF, Mors O, Budtz-J\u00f8rgensen E, et al. Long-term trajectories of positive and negative symptoms in first episode psychosis: a 10 year follow-up study in the OPUS cohort. Schizophr Res. 2015;168(1-2):84\u201391. https:\/\/doi.org\/10.1016\/j.schres.2015.07.021.","journal-title":"Schizophr Res."},{"key":"6683_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.schres.2016.10.030","volume":"182","author":"RS Wils","year":"2017","unstructured":"Wils RS, Gotfredsen DR, Hjorth\u00f8j C, et al. Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis. Schizophr Res. 2017;182:42\u20138. https:\/\/doi.org\/10.1016\/j.schres.2016.10.030.","journal-title":"Schizophr Res."},{"issue":"12","key":"6683_CR5","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1017\/S0033291717000563","volume":"47","author":"DR Gotfredsen","year":"2017","unstructured":"Gotfredsen DR, Wils RS, Hjorthoj C, et al. Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up. Psychol Med. 2017;47(12):2118\u201329. https:\/\/doi.org\/10.1017\/S0033291717000563.","journal-title":"Psychol Med."},{"issue":"3","key":"6683_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/wps.20442","volume":"16","author":"L Valmaggia","year":"2017","unstructured":"Valmaggia L. The use of virtual reality in psychosis research and treatment recent. World Psychiatry. 2017;16(3):246\u20137. https:\/\/doi.org\/10.1002\/wps.20442.","journal-title":"World Psychiatry."},{"issue":"1","key":"6683_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/schbul\/sbw132","volume":"43","author":"F Waters","year":"2017","unstructured":"Waters F, Fernyhough C. Hallucinations: a systematic review of points of similarity and difference across diagnostic classes. Schizophr Bull. 2017;43(1):32\u201343. https:\/\/doi.org\/10.1093\/schbul\/sbw132.","journal-title":"Schizophr Bull."},{"issue":"4","key":"6683_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/schbul\/sbs061","volume":"38","author":"F Lar\u00f8i","year":"2012","unstructured":"Lar\u00f8i F, Sommer IE, Blom JD, et al. The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions. Schizophr Bull. 2012;38(4):724\u201333. https:\/\/doi.org\/10.1093\/schbul\/sbs061.","journal-title":"Schizophr Bull."},{"issue":"JUNE","key":"6683_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1192\/bjp.166.6.773","volume":"166","author":"P Chadwick","year":"1995","unstructured":"Chadwick P, Birchwood M. The omnipotence of voices. II: The Beliefs About Voices Questionnaire (BAVQ). Br J Psychiatry. 1995;166(JUNE):773\u20136. https:\/\/doi.org\/10.1192\/bjp.166.6.773.","journal-title":"Br J Psychiatry."},{"key":"6683_CR10","doi-asserted-by":"publisher","unstructured":"Thomas N, Hayward M, Peters E, et al. Psychological therapies for auditory hallucinations (voices): current status and key directions for future research. Schizophr Bull. 2014;40(SUPPL. 4). https:\/\/doi.org\/10.1093\/schbul\/sbu037.","DOI":"10.1093\/schbul\/sbu037"},{"issue":"1","key":"6683_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.schres.2014.03.016","volume":"156","author":"M Van der Gaag","year":"2014","unstructured":"Van der Gaag M, Valmaggia LR, Smit F. The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis. Schizophr Res. 2014;156(1):30\u20137. https:\/\/doi.org\/10.1016\/j.schres.2014.03.016.","journal-title":"Schizophr Res."},{"issue":"183","key":"6683_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.schres.2016.11.019","volume":"2017","author":"M Hayward","year":"2017","unstructured":"Hayward M, Jones AM, Bogen-Johnston L, Thomas N, Strauss C. Relating therapy for distressing auditory hallucinations: a pilot randomized controlled trial. Schizophr Res. 2017;2017(183):137\u201342. https:\/\/doi.org\/10.1016\/j.schres.2016.11.019.","journal-title":"Schizophr Res."},{"key":"6683_CR13","doi-asserted-by":"publisher","unstructured":"Lincoln TM, Pillny M, Schlier B, Hayward M. RELATE-a randomised controlled feasibility trial of a relating therapy module for distressing auditory verbal hallucinations: a study protocol. BMJ Open. 2021;11(6). https:\/\/doi.org\/10.1136\/bmjopen-2020-046390.","DOI":"10.1136\/bmjopen-2020-046390"},{"issue":"2","key":"6683_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1017\/S1352465818000425","volume":"47","author":"S Louise","year":"2019","unstructured":"Louise S, Rossell SL, Thomas N. The acceptability, feasibility and potential outcomes of an individual mindfulness-based intervention for hearing voices. Behav Cogn Psychother. 2019;47(2):200\u201316. https:\/\/doi.org\/10.1017\/S1352465818000425.","journal-title":"Behav Cogn Psychother."},{"key":"6683_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/9781118499184.ch7","volume-title":"Acceptance and commitment therapy and mindfulness for psychosis","author":"N Thomas","year":"2013","unstructured":"Thomas N, Morris E, m. J, Shawyer F, Farhall J. Acceptance and commitment therapy for voices. In: Morris EMJ, Johns LC, Oliver JE, editors. Acceptance and commitment therapy and mindfulness for psychosis: Wiley; 2013. p. 95\u2013111."},{"issue":"1-2","key":"6683_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.psychres.2014.08.041","volume":"220","author":"J Chaix","year":"2014","unstructured":"Chaix J, Ma E, Nguyen A, Ortiz Collado MA, Rexhaj S, Favrod J. Safety-seeking behaviours and verbal auditory hallucinations in schizophrenia. Psychiatry Res. 2014;220(1-2):158\u201362. https:\/\/doi.org\/10.1016\/j.psychres.2014.08.041.","journal-title":"Psychiatry Res."},{"issue":"3","key":"6683_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1017\/S0033291720002238","volume":"52","author":"SF Fielding-Smith","year":"2022","unstructured":"Fielding-Smith SF, Greenwood KE, Wichers M, Peters E, Hayward M. Associations between responses to voices, distress and appraisals during daily life: an ecological validation of the cognitive behavioural model. Psychol Med. 2022;52(3):538\u201347. https:\/\/doi.org\/10.1017\/S0033291720002238.","journal-title":"Psychol Med."},{"issue":"2","key":"6683_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1348\/014466507X249093","volume":"47","author":"D Hacker","year":"2008","unstructured":"Hacker D, Birchwood M, Tudway J, Meaden A, Amphlett C. Acting on voices: omnipotence, sources of threat, and safety-seeking behaviours. Br J Clin Psychol. 2008;47(2):201\u201313. https:\/\/doi.org\/10.1348\/014466507X249093.","journal-title":"Br J Clin Psychol."},{"key":"6683_CR19","volume-title":"Incorporating acceptance and mindfulness into the treatment of psychosis: current trends and future directions","author":"N Thomas","year":"2015","unstructured":"Thomas N. A model for the development of acceptance and mindfulness\u2013based therapies: preoccupation with psychotic experiences as a treatment target. In: Gaudiano B, editor. Incorporating acceptance and mindfulness into the treatment of psychosis: current trends and future directions: Oxford University Press; 2015."},{"issue":"3","key":"6683_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1017\/S0033291717001945","volume":"48","author":"M Rus-Calafell","year":"2018","unstructured":"Rus-Calafell M, Garety P, Sason E, Craig TJK, Valmaggia LR. Virtual reality in the assessment and treatment of psychosis: a systematic review of its utility, acceptability and effectiveness. Psychol Med. 2018;48(3):362\u201391. https:\/\/doi.org\/10.1017\/S0033291717001945.","journal-title":"Psychol Med."},{"issue":"2","key":"6683_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cpr.2009.11.006","volume":"30","author":"A Mawson","year":"2010","unstructured":"Mawson A, Cohen K, Berry K. Reviewing evidence for the cognitive model of auditory hallucinations: the relationship between cognitive voice appraisals and distress during psychosis. Clin Psychol Rev. 2010;30(2):248\u201358. https:\/\/doi.org\/10.1016\/j.cpr.2009.11.006.","journal-title":"Clin Psychol Rev."},{"issue":"2","key":"6683_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1192\/bjp.164.2.190","volume":"164","author":"P Chadwick","year":"1994","unstructured":"Chadwick P, Birchwood M. The omnipotence of voices. Br J Psychiatry. 1994;164(2):190\u2013201. https:\/\/doi.org\/10.1192\/bjp.164.2.190.","journal-title":"Br J Psychiatry."},{"issue":"1","key":"6683_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S2215-0366(17)30427-3","volume":"5","author":"TK Craig","year":"2018","unstructured":"Craig TK, Rus-Calafell M, Ward T, et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2018;5(1):31\u201340. https:\/\/doi.org\/10.1016\/S2215-0366(17)30427-3.","journal-title":"Lancet Psychiatry."},{"key":"6683_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.schres.2018.02.031","volume":"197","author":"OP du Sert","year":"2018","unstructured":"du Sert OP, Potvin S, Lipp O, et al. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: a pilot clinical trial. Schizophr Res. 2018;197:176\u201381. https:\/\/doi.org\/10.1016\/j.schres.2018.02.031.","journal-title":"Schizophr Res."},{"key":"6683_CR25","doi-asserted-by":"publisher","unstructured":"Dellazizzo L, Potvin S, Phraxayavong K, Dumais A. One-year randomized trial comparing virtual reality-assisted therapy to cognitive\u2013behavioral therapy for patients with treatment-resistant schizophrenia. npj Schizophr. 2021;7(1). https:\/\/doi.org\/10.1038\/s41537-021-00139-2.","DOI":"10.1038\/s41537-021-00139-2"},{"issue":"6","key":"6683_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1192\/bjp.bp.112.124883","volume":"202","author":"J Leff","year":"2013","unstructured":"Leff J, Williams G, Huckvale MA, Arbuthnot M, Leff AP. Computer-assisted therapy for medication-resistant auditory hallucinations: proof-of-concept study. Br J Psychiatry. 2013;202(6):428\u201333. https:\/\/doi.org\/10.1192\/bjp.bp.112.124883.","journal-title":"Br J Psychiatry."},{"key":"6683_CR27","doi-asserted-by":"publisher","unstructured":"Aali G, Kariotis T, Shokraneh F. Avatar therapy for people with schizophrenia or related disorders. Cochrane Database Syst Rev. 2020;2020(5). https:\/\/doi.org\/10.1002\/14651858.CD011898.pub2.","DOI":"10.1002\/14651858.CD011898.pub2"},{"issue":"4","key":"6683_CR28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1017\/S0033291799008661","volume":"29","author":"G Haddock","year":"1999","unstructured":"Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(4):879\u201389. https:\/\/doi.org\/10.1017\/S0033291799008661.","journal-title":"Psychol Med."},{"issue":"2","key":"6683_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1017\/S0033291799001828","volume":"30","author":"M Birchwood","year":"2000","unstructured":"Birchwood M, Meaden A, Trower P, Gilbert P, Plaistow J. The power and omnipotence of voices: subordination and entrapment by voices and significant others. Psychol Med. 2000;30(2):337\u201344. https:\/\/doi.org\/10.1017\/S0033291799001828.","journal-title":"Psychol Med."},{"issue":"6","key":"6683_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jclp.20366","volume":"63","author":"F Shawyer","year":"2007","unstructured":"Shawyer F, Ratcliff K, Mackinnon A, Farhall J, Hayes SC, Copolov D. The voices acceptance and action scale (VAAS): pilot data. J Clin Psychol. 2007;63(6):593\u2013606.","journal-title":"J Clin Psychol."},{"key":"6683_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.schres.2020.03.003","volume":"220","author":"M Hayward","year":"2020","unstructured":"Hayward M, Schlier B, Strauss C, Rammou A, Lincoln T. Construction and validation of the approve questionnaires \u2013 measures of relating to voices and other people. Schizophr Res. 2020;220:254\u201360. https:\/\/doi.org\/10.1016\/j.schres.2020.03.003.","journal-title":"Schizophr Res."},{"issue":"2","key":"6683_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.psychres.2007.11.012","volume":"161","author":"H Nasrallah","year":"2008","unstructured":"Nasrallah H, Morosini PL, Gagnon DD. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia. Psychiatry Res. 2008;161(2):213\u201324. https:\/\/doi.org\/10.1016\/j.psychres.2007.11.012.","journal-title":"Psychiatry Res."},{"issue":"6","key":"6683_CR33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1017\/S0033291706007355","volume":"36","author":"D Fowler","year":"2006","unstructured":"Fowler D, Freeman D, Smith B, et al. The Brief Core Schema Scales (BCSS): psychometric properties and associations with paranoia and grandiosity in non-clinical and psychosis samples. Psychol Med. 2006;36(6):749\u201359. https:\/\/doi.org\/10.1017\/S0033291706007355.","journal-title":"Psychol Med."},{"key":"6683_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3200\/JRLP.139.5.439-457","volume":"139","author":"A Luszczynska","year":"2005","unstructured":"Luszczynska A, Luszczynska A. The General Self-Efficacy Scale: multicultural validation studies. J Psychol. 2005;139:439\u201357 https:\/\/pubmed.ncbi.nlm.nih.gov\/16285214\/The General Self-Efficacy Scale: Multicultural Validation Studies. J Psychol. 2005;139:439-457. https:\/\/pubmed.ncbi.nlm.nih.gov\/16285214\/.","journal-title":"J Psychol"},{"issue":"12","key":"6683_CR35","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/jclp.20836","volume":"67","author":"SE Melka","year":"2011","unstructured":"Melka SE, Lancaster SL, Bryant AR, Rodriguez BF. Confirmatory factor and measurement invariance analyses of the emotion regulation questionnaire. J Clin Psychol. 2011;67(12):1283\u201393. https:\/\/doi.org\/10.1002\/jclp.20836.","journal-title":"J Clin Psychol."},{"key":"6683_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archpsyc.1990.01810190015002","volume":"47","author":"NC Andreasen","year":"1993","unstructured":"Andreasen NC, Flaum M, Swayze VW, Tyrrell G, Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry. 1993;47:615\u201321.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"6683_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eurpsy.2015.01.014","volume":"30","author":"A Mucci","year":"2015","unstructured":"Mucci A, Galderisi S, Merlotti E, et al. The Brief Negative Symptom Scale (BNSS): independent validation in a large sample of Italian patients with schizophrenia. Eur Psychiatry. 2015;30(5):641\u20137. https:\/\/doi.org\/10.1016\/j.eurpsy.2015.01.014.","journal-title":"Eur Psychiatry."},{"issue":"3","key":"6683_CR38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/schbul\/sbv161","volume":"42","author":"S Dollfus","year":"2016","unstructured":"Dollfus S, Mach C, Morello R. Self-evaluation of negative symptoms. Schizophr Bull. 2016;42(3):571\u20138. https:\/\/doi.org\/10.1093\/schbul\/sbv161.","journal-title":"Schizophr Bull."},{"issue":"DEC. SUPPL. 22","key":"6683_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1192\/s0007125000292581","volume":"163","author":"D Addington","year":"1993","unstructured":"Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry. 1993;163(DEC. SUPPL. 22):39\u201344. https:\/\/doi.org\/10.1192\/s0007125000292581.","journal-title":"Br J Psychiatry."},{"issue":"1-2","key":"6683_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jad.2009.06.005","volume":"122","author":"EA Newnham","year":"2010","unstructured":"Newnham EA, Hooke GR, Page AC. Monitoring treatment response and outcomes using the World Health Organization\u2019s Wellbeing Index in psychiatric care. J Affect Disord. 2010;122(1-2):133\u20138. https:\/\/doi.org\/10.1016\/j.jad.2009.06.005.","journal-title":"J Affect Disord."},{"issue":"3","key":"6683_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0149-7189(79)90094-6","volume":"2","author":"DL Larsen","year":"1979","unstructured":"Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client\/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197\u2013207. https:\/\/doi.org\/10.1016\/0149-7189(79)90094-6.","journal-title":"Eval Program Plann."},{"issue":"8","key":"6683_CR42","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1176\/ajp.151.8.1132","volume":"151","author":"DP Bernstein","year":"1994","unstructured":"Bernstein DP, Fink L, Handelsman L, et al. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. 1994;151(8):1132\u20136.","journal-title":"Am J Psychiatry"},{"issue":"DEC.","key":"6683_CR43","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1192\/bjp.157.6.853","volume":"157","author":"M Birchwood","year":"1990","unstructured":"Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry. 1990;157(DEC.):853\u20139. https:\/\/doi.org\/10.1192\/bjp.157.6.853.","journal-title":"Br J Psychiatry."},{"issue":"4","key":"6683_CR44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/sltb.12084","volume":"44","author":"BA Van Spijker","year":"2014","unstructured":"Van Spijker BA, Batterham PJ, Calear AL, et al. The Suicidal Ideation Attributes Scale (SIDAS): community-based validation study of a new scale for the measurement of suicidal ideation. Suicide Life Threatening Behav. 2014;44(4):408\u201319.","journal-title":"Suicide Life Threatening Behav"},{"key":"6683_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ, Buysse DJ, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213 Published online 1989.","journal-title":"Psychiatry Res."},{"key":"6683_CR46","first-page":"588","volume":"63","author":"RS Kennedy","year":"1992","unstructured":"Kennedy RS, Fowlkes JE, Berbaum KS, Lilienthal MG. Use of a motion sickness history questionnaire for prediction of simulator sickness. Aviat Space Environ Med. 1992;63:588\u201393.","journal-title":"Aviat Space Environ Med."},{"issue":"1-3","key":"6683_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.schres.2006.04.024","volume":"89","author":"R Drake","year":"2007","unstructured":"Drake R, Haddock G, Tarrier N, Bentall R, Lewis S. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr Res. 2007;89(1-3):119\u201322. https:\/\/doi.org\/10.1016\/j.schres.2006.04.024.","journal-title":"Schizophr Res."},{"issue":"5","key":"6683_CR48","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/09602011.2015.1109524","volume":"27","author":"TD Parsons","year":"2017","unstructured":"Parsons TD, Carlew AR, Magtoto J, Stonecipher K. The potential of function-led virtual environments for ecologically valid measures of executive function in experimental and clinical neuropsychology. Neuropsychol Rehabil. 2017;27(5):777\u2013807. https:\/\/doi.org\/10.1080\/09602011.2015.1109524.","journal-title":"Neuropsychol Rehabil."},{"issue":"7","key":"6683_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1513\/pats.200706-072JK","volume":"4","author":"BT Thompson","year":"2007","unstructured":"Thompson BT, Schoenfeld D. Usual care as the control group in clinical trials of nonpharmacologic interventions. Proc Am Thorac Soc. 2007;4(7):577\u201382. https:\/\/doi.org\/10.1513\/pats.200706-072JK.","journal-title":"Proc Am Thorac Soc."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06683-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T07:10:08Z","timestamp":1663053008000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06683-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6683"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06683-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Committee on Health Research Ethics of the Capital Region Denmark and the Danish Data Protection Agency. Project-ID: H-19086621.Written informed consent will be obtained from all participants in the study, and participants have the right to withdraw from the study at any time and for any reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Consent for publication is not applicable as there are no identifying images of other personal details of participants presented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"773"}}